US Patent No. 9,476,098

Multigene prognostic assay for lung cancer
Oct 27, 2016

The University of California and Encore Clinical have been awarded US Patent No. 9,476,098, "Multigene prognostic assay for lung cancer."

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.